[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335764-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-335764-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","gender-specific-risks-for-incident-cancer-in-patients-with-different-heart-failure-phenotypes","Gender-specific risks for incident cancer in patients with different heart failure phenotypes","","This retrospective study evaluates whether heart failure (HF) increases the risk of developing incident cancer, with attention to gender differences and HF phenotypes. Adult individuals free of cancer at baseline were followed from 2009 to 2023, with HF categorized as preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF). HF patients showed a higher incidence of cancer, and the association remained after adjustment for confounders across genders and HF phenotypes.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/gender-specific-risks-for-incident-cancer-in-patients-with-different-heart-failure-phenotypes/335764/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/gender-specific-risks-for-incident-cancer-in-patients-with-different-heart-failure-phenotypes/335764.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the objective of this study?","Question",{"text":63,"@type":64},"To assess the association between heart failure and incident cancer, considering gender differences and heart failure phenotypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were heart failure phenotypes defined in the methods?",{"text":68,"@type":64},"Patients with HF were categorized into heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).",{"name":70,"@type":61,"acceptedAnswer":71},"What was the main result regarding cancer risk in patients with heart failure?",{"text":72,"@type":64},"After adjusting for confounders, patients with HF had a 58% increased risk of incident cancer compared with those without HF.",{"name":74,"@type":61,"acceptedAnswer":75},"Did the increased cancer risk differ by gender or HF phenotype?",{"text":76,"@type":64},"The increased risk was consistent across genders and across both HFpEF and HFrEF phenotypes.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},335764,1791170140,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,104,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},"Comic",60,"comic",{"id":105,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},6,"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":55,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":4},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","ESC HEART FAILURE ORIGINAL ARTICLE  \nESC Heart Failure 2025; 12: 497–507  \nPublished online 2 October 2024 in Wiley Online Library ([wileyonlinelibrary.com)](wileyonlinelibrary.com) DOI: 10.1002/ehf2.15097)[ DOI:](wileyonlinelibrary.com) DOI: 10.1002/ehf2.15097)[ 10.1002/ehf2.15097](wileyonlinelibrary.com) DOI: 10.1002/ehf2.15097)  \nGender-speciﬁc risks for incident cancer in patients with different heart failure phenotypes  \nQin-Fen Chen1,2, Christos S. Katsouras3, Chenyang Liu4, Jingjing Shi5, Xiaoqian Luan2,6, Chao Ni2, Hongxia Yao4,  \nYingdan Lu4, Wei-Hong Lin1 * and Xiao-Dong Zhou4 *   \n1Medical Care Center, First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, China; 2Institute of Aging, Key Laboratory of Alzheimer’s Disease of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Mental Disorders, Wenzhou Medical University, Wenzhou, China; 3First Department of Cardiology, University Hospital of Ioannina Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece; 4Department of Cardiovascular Medicine, the Heart Center, First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, China; 5Wenzhou Medical University Renji College, Wenzhou, China; and 6Department of Neurology, First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou, China  \nAbstract  \nBackground There is conﬂicting evidence regarding whether heart failure (HF) increases the risk of developing cancer. Objective This study aimed to assess the association between HF and incident cancer, considering gender differences and HF phenotypes.  \nMethods This retrospective study was conducted on data of adult individuals, free of cancer at baseline, from the First Afﬁliated Hospital of Wenzhou Medical University between January 2009 and February 2023 . The patients with HF were categorized as HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) . The primary outcome was incident cancer, including obesity-related, tobacco-related, lung, colorectal and breast cancers.  \nResults Of 33 033 individuals enrolled, 16 722 were diagnosed with HF, including 10 086 (60 .3%) with HFpEF and 6636 (39 .7%) with HFrEF. During a median follow-up period of 4 .6 years (inter-quartile range: 2 .6–7.3), incident cancer was diagnosed in 10 .5%(1707 patients) of the non-HF group and 15 . 1%(2533 individuals) of the HF group. After adjusting for potential confounding factors, patients with HF had a 58% increased risk of cancer than those without HF [adjusted hazard ratio (HR) 1.58, 95% conﬁdence interval (CI) 1 .48–1.69, P \u003C 0.001] . This risk was consistent across genders (female: adjusted HR 1 .95, 95% CI 1 .74–2. 18, P \u003C 0.001; male: adjusted HR 1 .41, 95% CI 1 .30–1.54, P \u003C 0.001) and HF phenotypes (HFpEF: adjusted HR 1 .69, 95% CI 1 .57–1.81, P \u003C 0.001; HFrEF: adjusted HR 1 .32, 95% CI 1 .20–1.46, P \u003C 0.001) .  \nConclusions Both HFpEF and HFrEF are associated with an increased risk of incident cancer. This correlation maintains its validity across genders.  \nKeywords cardio-oncology; cancer; heart failure; heart failure with reduced ejection fraction; heart failure with preserved ejection fraction; prognosis  \nReceived: 26 June 2024; Revised: 9 August 2024; Accepted: 11 September 2024  \n*Correspondence to: Xiao-Dong Zhou and Wei-Hong Lin, Department of Cardiovascular Medicine, Heart Center, First Afﬁliated Hospital of Wenzhou Medical University,  \nNanbaixiang, Wenzhou 325100, China. Email: [zhouxiaodong@wmu.edu.cn](zhouxiaodong@wmu.edu.cn) [and](and linweihong@wmu.edu.cn)[ linweihong@wmu.edu.cn](and linweihong@wmu.edu.cn)  \n[Co-](Co-)ﬁ[rst author: Qin-Fen Chen and Christos S](rst author: Qin-Fen Chen and Christos S). Katsouras.  \nIntroduction  \nCancer and heart failure (HF) are among the foremost contributors to global morbidity and mortality, collectively imposing asigniﬁcant disease burden worldwide.1–3 They often coexist, suggesting shared risk factors and underlying mechanisms.4–7","cbCaisLRGIY049N1","https://ap.wps.com/l/cbCaisLRGIY049N1","pdf",1453435,11,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Keywords","[{\"question\":\"What was the objective of this study?\",\"answer\":\"To assess the association between heart failure and incident cancer, considering gender differences and heart failure phenotypes.\"},{\"question\":\"How were heart failure phenotypes defined in the methods?\",\"answer\":\"Patients with HF were categorized into heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).\"},{\"question\":\"What was the main result regarding cancer risk in patients with heart failure?\",\"answer\":\"After adjusting for confounders, patients with HF had a 58% increased risk of incident cancer compared with those without HF.\"},{\"question\":\"Did the increased cancer risk differ by gender or HF phenotype?\",\"answer\":\"The increased risk was consistent across genders and across both HFpEF and HFrEF phenotypes.\"}]","Gender-specific risks for incident cancer in patients with different heart failure phenotypes | PDF",1790012243,28]